DSpace@İnönü

Yazar "Pala, C" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Yazar "Pala, C" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Sırala: Sıra: Sonuçlar:

  • The clinical characteristics and therapeutic outcomes of elderly 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, SK; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2014)
  • The clinical characteristics and therapeutic outcomes of elderly 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, SK; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2014)
  • The clinical characteristics and therapeutic outcomes of elderly 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, SK; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2014)
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...